FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
SUPREMEIND
1,393.3
-27.9 (-1.96%)
Updated 09:48 21/09 IST
SUPREMEIND Buy or Sell - FrontPage Forums
0 Users have submitted 0 trade ideas of Rs. 0 for SUPREMEIND
Disclaimer0% Bullish
0% Bearish
SUPREMEIND Buy or Sell - Brokerage Reports
No. of reports in last year
11
No. of analysts
6
Average Consensus Forecast
1353.64
Consensus Potential
-6.89%
SUPREMEIND Ratings
Long term SUPREMEIND rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
4.1/5 (9 Ratings)
Find answers to all your questions on live SUPREMEIND message board: Is SUPREMEIND buy or sell? Should I buy SUPREMEIND shares? Why are SUPREMEIND shares falling? Should I invest in SUPREMEIND stock?
- Home
- SUPREMEIND Forum
SUPREMEIND Share Price Discussion
N
Reputation: 6,008 • Sep 18 10:38 AM
Hold Supreme Industries; target of Rs 1457: CD Equisearch
CD Equisearch recommended hold rating on Supreme Industries with a target price of Rs 1457 in its research report dated September 18, 2020.
CD Equisearch recommended hold rating on Supreme Industries with a target price of Rs 1457 in its research report dated September 18, 2020.
Moneycontrol
Like
Reply
N
Reputation: 6,008 • Sep 18 10:38 AM
Reduce Solar Industries: target of Rs 924: ICICI Securities
ICICI Securities recommended Reduce rating on Solar Industries with a target price of Rs 924 in its research report dated September 17, 2020.
ICICI Securities recommended Reduce rating on Solar Industries with a target price of Rs 924 in its research report dated September 17, 2020.
Moneycontrol
Like
Reply
N
Reputation: 6,008 • Sep 18 10:38 AM
Hold Dr. Reddy's Lab; target of Rs 5325: Emkay Global Financial
Emkay Global Financial recommended hold rating on Dr. Reddy's Lab with a target price of Rs 5325 in its research report dated September 17, 2020.
Emkay Global Financial recommended hold rating on Dr. Reddy's Lab with a target price of Rs 5325 in its research report dated September 17, 2020.
Moneycontrol
Like
Reply
N
Reputation: 6,008 • Sep 18 10:38 AM
Buy Natco Pharma: target of Rs 954: ICICI Securities
ICICI Securities is bullish on Natco Pharma recommended buy rating on the stock with a target price of Rs 954 in its research report dated September 18, 2020.
ICICI Securities is bullish on Natco Pharma recommended buy rating on the stock with a target price of Rs 954 in its research report dated September 18, 2020.
Moneycontrol
Like
Reply
N
Reputation: 6,008 • Sep 18 10:38 AM
Hold Amber Enterprises India; target of Rs 2140: Emkay Global Financial
Emkay Global Financial recommended hold rating on Amber Enterprises India with a target price of Rs 2140 in its research report dated September 17, 2020.
Emkay Global Financial recommended hold rating on Amber Enterprises India with a target price of Rs 2140 in its research report dated September 17, 2020.
Moneycontrol
Like
Reply
B
Reputation: -1,541 • Sep 18 10:35 AM
#NTPC ....MADE W PATTERN ....TRADE FOR SHORT TERM DELIVERY & intraday
Like
Reply
I
Reputation: 805 • Sep 18 10:32 AM
Q. Miss behivaor user for qty
Hello sir
Some user miss behivaor for trading performance for many qty so I suggest to you stop miss behivaor user and seen real tusted trader. I suggest qty restrictions for any user 1 script only 2 ya 3 lots allow and not multiple trade at a time for same ...
Read more...
Like
Reply
N
Reputation: 591 • Sep 18 10:32 AM
Navas in MCX-CRUDEOILTrade entered: Sell CRUDEOIL 21SEP20 FUT @3016 ...
Tgt hit 21 point loss #CRUDEOIL
Like
Reply
A
Reputation: 428 • Sep 18 10:28 AM
Amit Patil in NIFTY-BANKTrade entered: Sell BANKNIFTY 24SEP20 23000 CE ...
Like
Reply
N
Reputation: 6,008 • Sep 18 10:28 AM
Buy Federal Bank: target of Rs 70: ICICI Securities
ICICI Securities is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 70 in its research report dated September 17, 2020.
ICICI Securities is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 70 in its research report dated September 17, 2020.
Moneycontrol
Like
Reply
N
Reputation: 6,008 • Sep 18 10:28 AM
Quant Pick - UltraTech Cement: ICICI Direct
According to ICICI Direct, Broader markets have started outperforming along with the Nifty. Select stocks from the infrastructure sector may witness renewed momentum amid a sustained broader market recovery.
According to ICICI Direct, Broader markets have started outperforming along with the Nifty. Select stocks from the infrastructure sector may witness renewed momentum amid a sustained broader market recovery.
Moneycontrol
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
SUPREMEIND Share Price - Technicals
- NewsBotSep 18 10:38 AMHold Supreme Industries; target of Rs 1457: CD EquisearchMoneycontrolNewsBotAug 21 4:43 AM
Supreme Industries shares jump 5% as Jefferies retains buy and raises target priceMoneycontrolNewsBotAug 3 9:28 AM
Sell Supreme Industries; target of Rs 1073: GeojitMoneycontrolNewsBotJul 30 12:38 PM
Reduce Supreme Industries; target of Rs 1227: Dolat CapitalMoneycontrolNewsBotJul 30 9:48 AM
Hold Supreme Industries; target of Rs 1245: ICICI DirectMoneycontrolNewsBotJul 30 9:08 AM
Buy Supreme Industries; target of Rs 1350 : SharekhanMoneycontrolNewsBotJul 27 3:18 AM
Supreme Ind Standalone June 2020 Net Sales at Rs 1,053.88 crore, down 26.65% Y-o-YMoneycontrolNewsBotJul 27 3:03 AM
Supreme Ind Consolidated June 2020 Net Sales at Rs 1,053.89 crore, down 26.65% Y-o-YMoneycontrolNewsBotJul 26 8:23 AM
Reduce Supreme Industries; target of Rs 1249: Dolat CapitalMoneycontrolNewsBotJun 18 3:28 AM
Supreme Industries share price jumps 5% after Axis Mutual Fund buys 12.25 lakh sharesMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.